Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Baby Pharm > Pharmacoeconomics PDF > Flashcards

Pharmacoeconomics PDF Flashcards

1
Q

T/F
Medicines account for the majority of total healthcare cost.

A

False
they are a small but significant proportion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some factors causing rising medication prices

A

new medicines marketed under patent law
drug therapy is preferred over invasive therapy
various off label-uses
irrational prescriptions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most common therapeutic intervention in medicine

A

writing a prescription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacoeconomics applies principles of health economics and applies them to _____.

A

pharmaceutical policy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Economic components of pharmacoeconomics

A

cost benefit
cost effectiveness
cost minimization
cost utility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

humanistic components of pharmacoeconomics

A

Quality of life
patient preference
patient satisfaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacoeconomics

A

the branch of economics that uses:
-cost-benefit
-cost-effectiveness
-cost-minimization
-cost-of-illness
-cost-utility analyses

to compare pharmaceutical products and treatment strategies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacoeconomics mainly works on health economics, focusing on…

A

costs/benefits of drug therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Health outcomes research, and patient-reported outcomes (PRO) in particular, aim at…

A

understanding patient value (impact of disease and
its treatment on physical functioning and psychosocial
wellbeing) –> “health-related quality of life” (HRQL).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Health care cost and demand are increasing in all countries due to…

A

improved/more sophisticated technology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

increased health care spending is due to…

A

increased life expectancy
increased technology
increased standard of living
increased demand for quality care/services

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factors that affect drug pricing

A

1.Sector: private more $
2.Procurement agent type
3.Distribution route: hospital pharmacies may cost more than public health sector distributive system
4.Patient status: patient in force = higher $$ for patented Rx

others:
patented vs generic
retail/wholesale markup
PharmD fees
Changes in population (ie: more old ppl)
MD prescribing habits
Newer drug vs. older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is pharmacoeconomics more important now?

A

increased emphasis on efficient drug therapies for a disease, which are more costly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacoeconomics is a branch of…

A

health economics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacoeconomics results from the health economics discipline coming of age through ___ to ___.

A

consolidation to disversification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacoeconomics
areas of need

A

-Industry- research/development alternatives.

-Government- program benefits and prices

-Private Sector- Designing insurance benefit coverage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

challenges to the pharmaceutical indutry

A

-blockbuster drugs going off-patent
-generic competition
-demand for innovative medicines
-rising drug development costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T/F
reducing costs and rationing resources is not compatible with the achievement of optimal health outcomes

A

true
must do cost:benefit analysis for best possible scenario

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how does pharmacoeconomic evaluation reduce monetary burden on the consumers

A

by insuring global pricing strategy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cost types

A

-financial cost (mandatory cost)
-economic cost (resource for which no mandatory payment is made)
-opportunity cost: benefit foregone when selecting one therapy alternative over the next best alternative

also:
direct, indirect and intangible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

the first step in any cost analysis is…

A

the identification of the various costs (direct, indirect and intangible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Direct Cost

A

costs from the perspective of the healthcare funder: including staff costs, capital costs, drug acquisition costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Indirect cost

A

not just the patient themselves but also their family and society as a whole

loss of earnings, loss of productivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Intangible Cost

A

pain, worry or other distress

sometimes reflected in quality of life measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Ways cost can be measured

A
  • Cost / unit
  • Cost / treatment
  • Cost / person
  • Cost / person / year
  • Cost / case prevented
  • Cost / life saved
  • Cost / DALY (disability-adjusted life year)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

second fundamental component of a pharmacoeconomic study is…

A

outcomes or benefits (cost benefit analysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Expected beenfits from an intervention may be measured in these 2 units…

A

Natural units: years of lives saved/strokes prevented

Utility units: satisfaction; quality of health, not just its quantity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

T/F
Pharamaeco. eval can be incorporated into clinical trials.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Why conduct a pharmaeco. eval into a clinical trial? (5)

A
  1. Pricing of a new drug
  2. Repricing of an old drug
  3. Convincing a drug formulatory
  4. Generation of data for promotional material
  5. Mandatory for drug licensing and medical reimbursement (in some countries).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

T/F
Pharmacoeconomic evaluations include any study designed to assess the costs (resources consumed) and consequences (clinical, humanistic) of newer therapies

A

False
assess consequences of alternative (not newer) therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

four types of pharmacoeconomic studies.

A

-Cost-minimization analysis (CMA)
-Cost-effectiveness analysis (CEA)
-Cost-utility analysis (CUA)
-Cost-benefit analysis (CBA)

32
Q

Cost-Minimization Analysis (CMA)

A
  • comparing multiple drugs of equal efficacy and equal tolerability

-comparing 2+ therapeutically equivalent agents or alternate dosing regimens of the same agent

-The option that has the least cost is selected

33
Q

Cost-Minimization Analysis (CMA) cannot be used to evaluate programs or therapies that….

A

lead to different outcomes

(compares equal efficacy/tolerability)

34
Q

Cost Effective Analysis (CEA)

A
  • aid in the selection of a course of action from various alternative approaches

-cost vs. effectiveness (cost/outcome)

-CANNOT compare two totally different areas of medicine with different outcomes

35
Q

most commonly applied form of economic analysis

A

cost effective analysis (CEA)

36
Q

ICER

A

incremental cost-effectiveness ratio

37
Q

Cost Utility Analysis (CUA)

A

-drugs/interventions with different outcomes can be compared

-good for life-extending Tx w/ serious side effects (e.g., cancer chemotherapy
or
-reductions in morbidity rather than mortality (e.g., medical treatment of arthritis)

38
Q

T/F
cost-utility analysis (CUA) is the most commonly employed analysis.

A

false
not common
lack of agreement on measuring utilities, difficulty comparing QALYs (quality adjusted life years) across patients and populations, and difficulty quantifying patient preferences

39
Q

When HRQOL (health-related quality of life) is the most important outcome, we use which cost analysis?

A

Cost utility analysis (CUA)

40
Q

____ can compare cost, quality, and the quantity of patient-years

A

Cost utility analysis (CUA)

41
Q

QALY (quality-adjusted life year) is a common measure of health status used in ____, combining ___ and ___ data.

A

CUA
morbidity
mortality

42
Q

cost-utility ratio (C:U ratio)

A

ratio is translated as the cost per QALY gained

QALY- quality-adjusted life year

43
Q

QALYs represent…

A

the number of full years at full health that are valued equivalently to the number of years as experience

ex: a full year of health in a disease free patient would equal 1.0 QALY. A year w/ a specific disease might be 0.5

44
Q

Cost Benefit Analysis (CBA)

A
  • most comprehensive and the most difficult
  • totally different interventions can be compared
    -costs and benefits do not occur simultaneously
    -programs with different objectives
45
Q

Cost Benefit Analysis (CBA) is expressed in…

A

as a ratio (a benefit-to-cost ratio), a net benefit, or a net cost

46
Q

Whats the challenge with Cost benefit analysis (CBA)?

A

-calculating the benefits in economic term

47
Q

T/F
The cost benefit analysis must always take into account intangible costs.

A

False
CBA may ignore intangible benefits (pain, anxiety, stress) that are difficult to express in monetary terms

48
Q

precision health economics is a branch of…

A

health economics

49
Q

precision health economics helps us…

A

-choose between two alternatives
-compare their clinical benefit on one hand and their cost on the other

50
Q

Whats the interest of the pharmacoeco. evaluation user?

A

where and how these results can help them for a better care of their patients

do not care about results themselves

51
Q

3 common types of perspectives in economic studies

A

producer
payer
social

52
Q

Which perspective is the most appropriate for making financial decisions?

A

society

53
Q

judgment must be made regarding a new drug’s additional benefits are worth the extra costs, therefore, whether it is ___.

A

cost effective

54
Q

One of the primary applications of pharmacoeconomics in
clinical practice today is to…

A

aid clinical and policy decision making.

55
Q

Complete pharmacotherapy decisions should contain assessments of three basic outcome areas whenever appropriate:

A

economic, clinical, and humanistic outcomes (ECHO)

56
Q

Pharmacoeconomic data can support various clinical decisions, ranging from the level of the patient to…

A

the level of an entire healthcare system

57
Q

application of pharmacoeconomics to decision making is divided into two basic areas:

A

-drug therapy eval
-clinical pharmacy service evaluation

58
Q

____ of a firm’s products may be equated to its corporate value.

A

QALYs

59
Q

Applied pharmacoeconomics is defined as

A

putting pharmacoeconomic principles, methods, and theories into practice to quantify the value of pharmacy products and pharmaceutical care services

60
Q

helps practitioners justify the value of the products and services

A

applied pharmacoeconomics

61
Q

Dutch Guidelines for Pharmacoeconomic Research

A

designing, conducting and reporting pharmacoeconomic research

62
Q

Guideline 1 - The perspective of the evaluation
The pharmacoeconomic evaluation should be performed and reported from a ____ perspective, in which all costs and benefits are included

A

societal

63
Q

Guideline 2 - Choice of comparative treatment/ indication
The drug for a certain indication should be compared with ______, or if that does not exist, the usual treatment

A

the standard treatment

64
Q

Guideline 3 - Analytical technique
If the improvement in quality of life forms an important effect of the drug being assessed, we must perform a ___.

A

Cost-utility analysis (CUA)

if the above is not the case, a CEA must be done (cost-effectiveness analysis)

65
Q

(Guideline 3)
If the manufacturer does not expect the drug to have an added therapeutic value or mutually replaceable with (a) different drug(s), then a ___ can be carried out.

A

CMA (cost minimization analysis)

66
Q

Why do we use the Manual for cost research?

A

promote the uniformity and the standardization of cost measurement and evaluation

67
Q

Guideline 6
Health states and survival data need to be reported ___.

A

separately

68
Q

Guideline 7
The model used is preferred to be ___.

A

peer reviewed

69
Q

Guideline 8
The cost-effectiveness of the treatments to be compared is presented by reporting the ___ and ___ between the treatments.

A

incremental effects and costs

70
Q

Guideline 9
If data on effects and costs are collected over a period longer than ____, effects and costs must be discounted after ___.

A

1 year
the first year

71
Q

Guideline 9
How are the costs and effects discounted?

A

data must be collected over a time period >1 Yr

start discounts after the first year

primary analysis = 4 % discount
onward = 1.5%

72
Q

Guideline 10
Sensitivity analysis

A
  • formulate an upper and a lower limit for each estimate reflecting the uncertainty margins

-examines the effect of simultaneous alterations in various variables

-accounts for correlation btwn the variables

73
Q

Guideline 11
Expert panel

A

pharmacoeconomic evaluation provided by the expert panel

74
Q

There’s an urgent need to develop a science based on study of ___ and ___ to healthcare system and society.

A

cost
drug therapy

75
Q

How is pharmacoec. relevant to socioeconomics?

A

it relates patients, society and economy, to drug therapy

76
Q

T/F
There is a solid concensus in pharmacoeconomic guidelines.

A

False
majority are vague and general

no consensus among the developers

77
Q

Overall recommendation from the authors of the pharmacoeconomics PDF

A
  1. strict guidelines w/ uniform global standards by an independent body (people from academia, industry and health authorities)
  2. this would help in reducing the monetary burden on institutions and public

Baby Pharm (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions